期刊文献+

噬菌体改组库的构建及高活性水蛭素变异体的筛选 被引量:1

Construction of phage-displayed library by DNA shuffling and the screening of potent hirudin variants
原文传递
导出
摘要 目的:运用DNA家族改组方法提高水蛭素的抗凝血酶活性。方法:将水蛭素HV1、HV2、HV3基因等量混合,用DNaseI消化,回收50bp左右的片段,再经无引物和有引物PCR扩增获得与原基因大小相同的改组分子,构建噬菌体展示的水蛭素改组文库,经凝血酶亲和淘选,ELISA筛选高活性的水蛭素变异体。结果:经过DNA改组和噬菌体亲和筛选,成功获得抗凝血酶活性提高的水蛭素变异体HV2-N47K。结论:用DNA家族改组及亲和淘选技术能够筛选出高活性的水蛭素变异体蛋白,这为其他分子的改组提供了借鉴。 AIM: To directed promote the antithrombotic activity of hirudin in vitro with DNA family shuffling method. METHODS: PCR products of HV1, HV2 and HV3 genes of hirudin were combined and digested by DNase I. Then random fragments about 50 bp were purified and reassembled to the same size of hirudin gene by two amplifications of PCR with or without primers. The shuffled hirudin genes were inserted into phagemid pCANTAB5E vector and the hirudin mutants were displayed on the surface of bacteriophage M13. Mutants with increased specific activity of antithrombin were screened by affinity panning with decreased amounts of thrombin, RESULTS, After shuffling and selection, a clone (HV2-N47K) with high antithrombotic activity was obtained, CONCLUSION: Hirudin variants with improved properties could be hopefully aquired by DNA family shuffling and affinity panning.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2006年第2期167-170,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(No.30200359)
关键词 水蛭素 DNA改组 亲和淘选 hirudin DNA reshuffle affinity panning
  • 相关文献

参考文献11

  • 1Sohn JH,Kang HA,Rao KJ,et al.Current status of the anticoagulant hirudin:its biotechnological production and clinical practice[J].Appl Microbiol Biotechnol,2001,57(5-6):606-613.
  • 2Yavin YY,Wolozinsky M,Cohen AT.New antithrombotics in the prevention of thromboembolic disease[J].Eur J Intern Med,2005,16(4):257-266.
  • 3Markwardt F.Hirudin as alternative anticoagulant-a historical review[J].Semin Thromb Hemost,2002,28(5):405-414.
  • 4Locher CP,Soong NW,Whalen RG,et al.Development of novel vaccines using DNA shuffling and screening strategies[J].Curr Opin Mol Ther,2004,6(1):34-39.
  • 5龙铟,刘家云,刘莉,王宗仁.水蛭素基因毕赤酵母表达载体的构建及高拷贝稳定整合菌株的筛选[J].第四军医大学学报,2004,25(13):1228-1231. 被引量:4
  • 6Yuan L,Kurek I,English J,et al.Laboratory-directed protein evolution[J].Microbiol Mol Biol Rev,2005,69(3):373-392.
  • 7Graddis TJ,Remmele RL Jr,McGrew JT.Designing proteins that work using recombinant technologies[J].Curr Pharm Biotechnol,2002,3(4):285-297.
  • 8Pini A,Giuliani A,Ricci C,et al.Strategies for the construction and use of peptide and antibody libraries displayed on phages[J].Curr Protein Pept Sci,2004,5(6):487-496.
  • 9Zhang XX,Deng Q,Zhang SY,et al.Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library[J].J Med Virol,2003,71(4):511-517.
  • 10赵小玲,荫俊,王慧,姜明,侯小军.人源抗狂犬病毒单链抗体库的构建及体外亲和筛选[J].细胞与分子免疫学杂志,2004,20(2):243-247. 被引量:11

二级参考文献21

  • 1Wilkerson JA. Rabies update. Wilderness Environ [ J]. Medicine,2000, 11(1): 31 -39.
  • 2Cheung SC, Dietzschold B, Koprowski H, et al. A recombinant human Fab expressed in Escherichia colt neutralizes rabies virus [J]. JVirol, 1992, 66(11): 6714 -6720.
  • 3Muller B H, Lafay F, Demangel C, et al. Phage-displayed and soluble mouse scFv kagments neutralizes rabies virus [ J]. J Virol Methods, 1997, 67(2): 221 -233.
  • 4Nagesha HS, Wang LF, Shiell B, et al. A single chain Fy antibodydisplayed on phage surface recognises conformational group-specificepitope of bluetongue virus [ J ]. J Virol Methods, 2001 , 91 ( 2 ):203 - 207.
  • 5James DM, Hennie RH, Timithy PB, et al. By-passing immunizationhuman antibodies from V-gene libraries displayed on phage[ J ]. J MolBiol, 1991, 222:581 -597.
  • 6Ray K, Embleton MJ, Jailkhani BL, et al. Selection of single chainvariable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and theirfusion with the Fc region of human IgG1 [ J ]. Clin
  • 7Aujame L, Geoffroy F, Sodoyer. High affinity human antibodies byphage display [ J]. Human Antibodies, 1997, 8: 155 - 168.
  • 8Champion JM, Kean RB, Rupprencht CE, et al. The development ofmonoclonal human rabies virus-neuralizing antibodies as a substitutefor pooled human immunoglobulin in the prophylactic treatment ofrabies virus exposure [ J ]. J Immunol Methods, 2000, 235 ( 1
  • 9Ruef J, Katus HA. New antithrombotic drugs on the horizon[J]. Expert Opin Investig Drugs, 2003; 12(5):781-797.
  • 10Markwardt F. Hirudin as alternative anticoagulantA historical review[J]. Semin Thromb Hemost, 2002; 28(5):405-414.

共引文献15

同被引文献7

  • 1龙铟,刘家云,刘莉,王宗仁.水蛭素基因毕赤酵母表达载体的构建及高拷贝稳定整合菌株的筛选[J].第四军医大学学报,2004,25(13):1228-1231. 被引量:4
  • 2Markwardt F. Hirudin as alternative anticoagulant-a historical review[J]. Semin Thromb Hemost, 2002,28(5) :405 -414.
  • 3Sohn JH, Kang HA, Rao KJ, et al. Current status of the anticoagulant hirudin: its biotechnological production and clinical practice [J]. Appl Microbiol Biotechnol, 2001,57(5-6) :606 -613.
  • 4Yavin YY, Wolozinsky M, Cohen AT. New antithrombotics in the prevention of thromboembolic disease[J]. Eur J Intern Med, 2005, 16(4) :257 -266.
  • 5Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris [ J ]. FEMS Microbiol Rev, 2000,24( 1 ) :45 -66.
  • 6Boettner M, Prinz B, Holz C, et al. High-throughput screening for expression of heterologous proteins in the yeast Pichia pastoris [ J ].J Biotechnol, 2002,99( 1 ) :51 -62.
  • 7Daly R, Hearn MT. Expression of heterologous proteins in Pichia pastoris: A useful experimental tool in protein engineering and production[J]. J Mol Recognit, 2005,18(2) :119 -138.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部